Crossref
journal-article
Elsevier BV
Trends in Microbiology (78)
References
83
Referenced
168
10.1002/hep.1840360703
/ Hepatology / National institutes of health consensus development conference statement: Management of hepatitis C: 2002–June 10-12, 2002 (2002)- Penin, F. et al. Structural biology of hepatitis C virus. Hepatology (in press).
10.1007/BF00191948
/ Med. Microbiol. Immunol. (Berl.) / Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins by Thomssen (1993){'key': '10.1016/j.tim.2003.12.005_BIB4', 'first-page': '991', 'article-title': 'Flaviviridae: the viruses and their replication', 'volume': 'Vol. 1', 'author': 'Lindenbach', 'year': '2001'}
/ Flaviviridae: the viruses and their replication by Lindenbach (2001)10.1099/0022-1317-82-11-2589
/ J. Gen. Virol. / Biogenesis of hepatitis C virus envelope glycoproteins by Op De Beeck (2001)10.1128/JVI.75.12.5703-5710.2001
/ J. Virol. / Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment by Penin (2001)10.1074/jbc.M302267200
/ J. Biol. Chem. / Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate by Barth (2003)10.1073/pnas.96.22.12766
/ Proc. Natl. Acad. Sci. U. S. A. / Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor by Agnello (1999)10.1126/science.282.5390.938
/ Science / Binding of hepatitis C virus to CD81 by Pileri (1998)10.1074/jbc.M305289200
/ J. Biol. Chem. / Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor by Bartosch (2003)10.1073/pnas.0832180100
/ Proc. Natl. Acad. Sci. U. S. A. / Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles by Hsu (2003)10.1093/emboj/cdf529
/ EMBO J. / The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus by Scarselli (2002)10.1074/jbc.M301284200
/ J. Biol. Chem. / DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2 by Lozach (2003)10.1128/JVI.77.7.4070-4080.2003
/ J. Virol. / Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR by Pohlmann (2003)10.1128/JVI.77.1.546-559.2003
/ J. Virol. / Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes by Saunier (2003)10.1128/JVI.66.3.1476-1483.1992
/ J. Virol. / Internal ribosome entry site within hepatitis C virus RNA by Tsukiyama-Kohara (1992)10.1126/science.1058409
/ Science / Hepatitis C virus IRES RNA-induced changes in the conformation of the 40S ribosomal subunit by Spahn (2001){'key': '10.1016/j.tim.2003.12.005_BIB18', 'first-page': '370', 'article-title': 'Crystal structure of an RNA tertiary domain essential to HCV IRES-mediated translation initiation', 'volume': '9', 'author': 'Kieft', 'year': '2002', 'journal-title': 'Nat. Struct. Biol.'}
/ Nat. Struct. Biol. / Crystal structure of an RNA tertiary domain essential to HCV IRES-mediated translation initiation by Kieft (2002)10.1128/JVI.67.3.1385-1395.1993
/ J. Virol. / Expression and identification of hepatitis C virus polyprotein cleavage products by Grakoui (1993)10.1016/S0014-5793(02)03851-6
/ FEBS Lett. / The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine by Griffin (2003)10.1073/pnas.1031527100
/ Proc. Natl. Acad. Sci. U. S. A. / The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives by Pavlovic (2003)10.1128/JVI.77.2.1578-1583.2003
/ J. Virol. / Hepatitis C virus F protein is a short-lived protein associated with the endoplasmic reticulum by Xu (2003)10.1099/vir.0.19065-0
/ J. Gen. Virol. / Characterization of the expression of the hepatitis C virus F protein by Roussel (2003)10.1046/j.1365-2893.1999.00185.x
/ J. Viral Hepat. / The non-structural 5A protein of hepatitis C virus by Pawlotsky (1999)10.1038/nri888
/ Nat. Rev. Immunol. / Viruses and interferon: a fight for supremacy by Katze (2002)10.1128/JVI.75.13.6095-6106.2001
/ J. Virol. / Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response by Polyak (2001)10.1128/JVI.76.12.5974-5984.2002
/ J. Virol. / Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex by Egger (2002)10.1084/jem.194.10.1395
/ J. Exp. Med. / Determinants of viral clearance and persistence during acute hepatitis C virus infection by Thimme (2001)10.1073/pnas.202608299
/ Proc. Natl. Acad. Sci. U. S. A. / Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease by Thimme (2002)10.1073/pnas.202608199
/ Proc. Natl. Acad. Sci. U. S. A. / Genomic analysis of the host response to hepatitis C virus infection by Su (2002)10.4049/jimmunol.170.3.1249
/ J. Immunol. / Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection by Jinushi (2003)10.1084/jem.20011145
/ J. Exp. Med. / Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions by Tseng (2002)10.1084/jem.20011124
/ J. Exp. Med. / Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein by Crotta (2002)10.1126/science.1082604
/ Science / Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease by Foy (2003)10.1016/S0016-5085(03)00290-7
/ Gastroenterology / Expression of hepatitis C virus proteins inhibits interferon alpha signaling in the liver of transgenic mice by Blindenbacher (2003)10.1073/pnas.91.16.7792
/ Proc. Natl. Acad. Sci. U. S. A. / Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization by Farci (1994)10.1006/viro.1996.0497
/ Virology / A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures by Shimizu (1996)10.1084/jem.20021756
/ J. Exp. Med. / Infectious hepatitis C virus pseudo-particles containing functional E1–E2 envelope protein complexes by Bartosch (2003)10.1093/emboj/17.13.3521
/ EMBO J. / Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants by Puntoriero (1998)10.4049/jimmunol.167.7.3878
/ J. Immunol. / Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles by Cerino (2001)10.1053/jhep.2003.50310
/ Hepatology / Kinetics of the immune response during HBV and HCV infection by Bertoletti (2003)10.1053/gast.2001.21212
/ Gastroenterology / Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection by Bain (2001)10.1046/j.0818-9641.2002.01138.x
/ Immunol. Cell Biol. / Immune responses in hepatitis C virus infection: the role of dendritic cells by Fowler (2003)10.4049/jimmunol.169.6.3447
/ J. Immunol. / Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection by Wedemeyer (2002)10.1038/nm0402-379
/ Nat. Med. / Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections by Appay (2002)10.1084/jem.191.9.1499
/ J. Exp. Med. / Analysis of successful immune responses in persons infected with hepatitis C virus by Lechner (2000)10.1172/JCI10323
/ J. Clin. Invest. / Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation by Kittlesen (2000)10.1172/JCI119778
/ J. Clin. Invest. / Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus by Chang (1997)10.1016/S1074-7613(01)00245-X
/ Immunity / The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes by Erickson (2001)10.1053/gast.2002.33428
/ Gastroenterology / Molecular diagnosis of viral hepatitis by Pawlotsky (2002)10.1126/science.282.5386.103
/ Science / Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy by Neumann (1998)10.1016/S1089-3261(02)00063-6
/ Clin. Liver Dis. / Mathematical modeling of viral kinetics: a tool to understand and optimize therapy by Layden (2003)10.1053/jhep.2003.50267
/ Hepatology / Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C by Poynard (2003)10.1096/fj.01-0396com
/ FASEB J. / Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis by Perlemuter (2002)10.1073/pnas.94.4.1200
/ Proc. Natl. Acad. Sci. U. S. A. / Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets by Barba (1997)10.1016/S0168-8278(00)80166-X
/ J. Hepatol. / Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 by Rubbia-Brandt (2000)10.1016/S0168-8278(00)00036-2
/ J. Hepatol. / Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C by Serfaty (2001)10.1136/gut.52.2.288
/ Gut / Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies by Castera (2003)10.7326/0003-4819-138-3-200302040-00012
/ Ann. Intern. Med. / Hepatitis C in the HIV-infected Person by Sulkowski (2003)10.1053/snep.2002.33674
/ Semin. Nephrol. / HCV infection and hemodialysis by Pol (2002)10.1097/00042737-199705000-00015
/ Eur. J. Gastroenterol. Hepatol. / In-situ immunophenotyping study of hepatic-infiltrating cytotoxic cells in chronic active hepatitis C by Fiore (1997)10.1016/S0016-5085(97)70235-X
/ Gastroenterology / Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections by Bertoletti (1997)10.1002/hep.510240402
/ Hepatology / Progressive liver injury in chronic hepatitis C infection correlates with increased intra-hepatic expression of Th1-associated cytokines by Napoli (1996)10.1023/A:1006694627907
/ J. Clin. Immunol. / Relationship between interferon-gamma, interleukin-10, and interleukin-12 production in chronic hepatitis C and in vitro effects of interferon-alpha by Piazzolla (2000)10.4049/jimmunol.158.11.5283
/ J. Immunol. / Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL by Ando (1997)10.1038/nm0497-409
/ Nat. Med. / Essential roles of the Fas ligand in the development of hepatitis by Kondo (1997)10.1016/S1089-3261(02)00076-4
/ Clin. Liver Dis. / Approaches for treatment of liver fibrosis in chronic hepatitis C by Bedossa (2003){'key': '10.1016/j.tim.2003.12.005_BIB68', 'first-page': '69', 'article-title': 'Hepatic fibrogenesis and hepatitis C', 'volume': '11', 'author': 'Rockey', 'year': '2000', 'journal-title': 'Semin. Gastrointest. Dis.'}
/ Semin. Gastrointest. Dis. / Hepatic fibrogenesis and hepatitis C by Rockey (2000){'key': '10.1016/j.tim.2003.12.005_BIB69', 'first-page': '101', 'article-title': 'Hepatic stellate cells', 'volume': '14', 'author': 'Friedman', 'year': '1996', 'journal-title': 'Prog. Liver Dis.'}
/ Prog. Liver Dis. / Hepatic stellate cells by Friedman (1996)10.1074/jbc.275.4.2247
/ J. Biol. Chem. / Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury by Friedman (2000)10.1016/S0168-8278(02)00429-4
/ J. Hepatol. / Liver fibrosis – from bench to bedside by Friedman (2003)10.1002/hep.1840360728
/ Hepatology / Alcohol use and hepatitis C by Peters (2002)10.1046/j.1365-2036.2003.01546.x
/ Aliment. Pharmacol. Ther. / Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study by Hezode (2003)10.1053/gast.2002.33023
/ Gastroenterology / Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C by Poynard (2002)10.1002/hep.1840360710
/ Hepatology / Hepatocellular carcinoma and hepatitis C in the United States by El-Serag (2002)10.1128/JVI.70.7.4438-4443.1996
/ J. Virol. / Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype by Ray (1996)10.1006/viro.2000.0295
/ Virology / Hepatitis C virus core protein promotes immortalization of primary human hepatocytes by Ray (2000)10.1128/JVI.69.6.3893-3896.1995
/ J. Virol. / Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells by Sakamuro (1995)10.1006/bbrc.1999.1999
/ Biochem. Biophys. Res. Commun. / Hepatitis C virus nonstructural protein NS4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene by Park (2000)10.1099/0022-1317-80-5-1179
/ J. Gen. Virol. / Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth by Ghosh (1999)10.1038/2053
/ Nat. Med. / The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice by Moriya (1998)10.1053/gast.2002.31001
/ Gastroenterology / Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus by Lerat (2002)10.1016/S1089-3261(02)00071-5
/ Clin. Liver Dis. / Tissue culture and animal models for hepatitis C virus by Pietschmann (2003)
Dates
Type | When |
---|---|
Created | 21 years, 7 months ago (Jan. 7, 2004, 5:37 a.m.) |
Deposited | 2 years, 4 months ago (April 27, 2023, 2:16 p.m.) |
Indexed | 4 weeks, 1 day ago (July 30, 2025, 11:08 a.m.) |
Issued | 21 years, 6 months ago (Feb. 1, 2004) |
Published | 21 years, 6 months ago (Feb. 1, 2004) |
Published Print | 21 years, 6 months ago (Feb. 1, 2004) |
@article{Pawlotsky_2004, title={Pathophysiology of hepatitis C virus infection and related liver disease}, volume={12}, ISSN={0966-842X}, url={http://dx.doi.org/10.1016/j.tim.2003.12.005}, DOI={10.1016/j.tim.2003.12.005}, number={2}, journal={Trends in Microbiology}, publisher={Elsevier BV}, author={Pawlotsky, Jean-Michel}, year={2004}, month=feb, pages={96–102} }